Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline

Authors

Ghady Haidar

Published

September 3, 2024

Add a comment...

Supporters

Support the authors with ResearchCoin

Journal

JAC-Antimicrobial Resistance

Topics

DOI

10.1093/jacamr/dlae141

License

CC-BY

Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline

Authors

Ghady Haidar

Published

September 3, 2024

Add a comment...

Supporters

Support the authors with ResearchCoin

Journal

JAC-Antimicrobial Resistance

Topics

DOI

10.1093/jacamr/dlae141

License

CC-BY

Paper

Paper

Paper

Paper

Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline

Supporters

Journal

Topics

DOI

License

Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline

Supporters

Journal

Topics

DOI

License

Supporters

Journal

Topics

DOI

License